Strinic D, Petrovic A, Balenovic D, et al
danuglipron oral GLP-1 discontinued 2024 Key Peptide Products: Somavert (pegvisomant GH receptor antagonist), Genotropin (somatropin growth hormone peptide), BNT116/mRNA oncology vaccines, historical insulin franchise, Lupron (leuprolide US rights via Abbvie partnership) Therapeutic Segments: Oncology (Ibrance, Xtandi partnership, Padcev, Lorbrena)
Hexarelin Description: A growth hormone secretagogue that promotes muscle growth, fat loss, recovery, and cardiac health
Peptide Therapy That Delivers Results Our customized peptide therapy programs are designed around your specific health goalshelping improve energy levels, metabolism, and cellular performance